Interventions for valvular disease
First pilot study with the TriGUARD 3 Cerebral Embolic Protection Device February 25, 2020 | 10.4244/EIJ-D-19-00741
Showing 1-20 of 4157 articles
Coronary interventions
Coronary sinus Reducer implantation results in improved oxygen kinetics at cardiopulmonary exercise test in patients with refractory angina February 25, 2020 | 10.4244/EIJ-D-19-00766
Coronary interventions
Short-Duration Triple Antithrombotic Therapy for Atrial Fibrillation Patients Who Require Coronary Stenting: Results of the SAFE-A Study February 25, 2020 | 10.4244/EIJ-D-19-00920
Interventions for valvular disease
Transcatheter Structural Heart Disease Intervention –From ready-made to custom-made therapy February 25, 2020 | 10.4244/EIJ-D-19-01061
Interventions for valvular disease
Predictors and Safety of Next-Day Discharge in Unselected Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation February 25, 2020 | 10.4244/EIJ-D-19-01080
Coronary interventions
TAVR-in-TAVR and Coronary Access: The Importance of Pre-procedural Planning February 25, 2020 | 10.4244/EIJ-D-19-01094
Coronary interventions
The year in review 2019: Coronary interventions February 25, 2020 | 10.4244/EIJ-D-19-01124
Coronary interventions
Safety of Absolute Coronary Flow And Microvascular Resistance Measurements by Thermodilution February 25, 2020 | 10.4244/EIJ-D-20-00074
Coronary interventions
Absorb Bioresorbable Vascular Scaffold is Associated with Low Wall Shear Stress Compared to Xience V: A Biomechanical Analysis of the Absorb III Imaging Study. February 23, 2020 | 10.4244/EIJ-D-19-01128
Will your Heart Team EXCEL?
February 20, 2020 | 10.4244/EIJV15I14A217
All that glitters is not gold: can videodensitometry replace echocardiography for the assessment of paravalvular aortic regurgitation?
February 20, 2020 | 10.4244/EIJV15I14A218
Going ultra!
February 20, 2020 | 10.4244/EIJV15I14A219
Clinical outcome after interventions with paclitaxel-coated balloons: a PCR statement
February 20, 2020 | 10.4244/EIJV15I14A220
Involving the patient’s perspective and preferences concerning coronary angiography and percutaneous coronary intervention
February 20, 2020 | 10.4244/EIJV15I14A221
Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves
February 20, 2020 | 10.4244/EIJ-D-19-00710
In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry
February 20, 2020 | 10.4244/EIJ-D-19-00541
Midterm procedural and clinical outcomes of percutaneous paravalvular leak closure with the Occlutech Paravalvular Leak Device
February 20, 2020 | 10.4244/EIJ-D-19-00517
Feasibility of quantitative assessment of aortic regurgitation in a percutaneous closure of paravalvular leak: expanding videodensitometry
February 20, 2020 | 10.4244/EIJ-D-19-00118